about
Dietary interventions for mineral and bone disorder in people with chronic kidney diseaseAuricular acupressure on specific points for hemodialysis patients with insomnia: a pilot randomized controlled trial.Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney diseaseEfficacy and Safety of Sanfu Herbal Patch at Acupoints for Persistent Allergic Rhinitis: Study Protocol for a Randomized Controlled Trial.Ginkgo biloba Extract for Patients with Early Diabetic Nephropathy: A Systematic ReviewColon may provide new therapeutic targets for treatment of chronic kidney disease with Chinese medicine.Oral Astragalus (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children.Traditional Medicines and Kidney Disease in Low- and Middle-Income Countries: Opportunities and Challenges.Chronic kidney disease is associated with poorer in-hospital outcomes in patients hospitalized with infections: Electronic record analysis from China.eGFR and the Risk of Community-Acquired Infections.Auricular acupressure for insomnia in hemodialysis patients: study protocol for a randomized controlled trial.Association of Kidney Function with Infections by Multidrug-Resistant Organisms: An Electronic Medical Record AnalysisAssociation between reduced renal function and cardiovascular mortality in patients hospitalized with infection: A multi-center cohort study[A survey and analysis of Chinese patent medicine for outpatients with chronic kidney disease]Vitamin D deficiency and treatment versus risk of infection in end-stage renal disease patients under dialysis: a systematic review and meta-analysisEstimated Glomerular Filtration Rate and the Risk of Cancer
P50
Q24187142-008BF7DA-C124-433F-8587-663B32B1504CQ35431344-27F857B0-30BC-41CD-8AD0-4C48370AAB5EQ35767340-53FD51CC-5301-4AA0-9E28-1D8768DE93ABQ35957750-1513DD1F-8BF1-4886-93FC-898BAEB0DB94Q36679039-1E785062-E776-4EC8-8171-00A262C50409Q38078286-8D9605F2-0BE9-4FA1-A49F-ECB3FF29953EQ38375392-B288A782-1C48-4811-9E2C-FDDD031AE18DQ39322937-908E9B88-8976-4A95-AD0C-550B8705C0E5Q40045013-E30E3B1C-4A13-48FF-A00E-064CE0E18057Q40079029-C3DADB24-83E3-4A24-97D7-8356EDAB6893Q51743326-76B7403C-C998-4A55-AF7B-8AA7F35EECF1Q58761928-611EC9DB-3B9A-4DF8-9283-CA8B567B56FEQ64137221-4BF30C60-B3B4-47F9-A510-75C39B7CDDA6Q84937253-138C8E80-3005-48E6-9846-6C52521E093DQ90636393-18B6250B-3A74-4C0A-89B7-4A91A703C2C9Q92369070-6E7BBC5C-44EB-479E-AC8A-236309E91F7A
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0001-5073-9848
@en
name
Guobin Su
@ast
Guobin Su
@en
Guobin Su
@nl
type
label
Guobin Su
@ast
Guobin Su
@en
Guobin Su
@nl
prefLabel
Guobin Su
@ast
Guobin Su
@en
Guobin Su
@nl
P106
P31
P496
0000-0001-5073-9848